Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.64%+6.67%+53.59%+154.11% 1,063B
+0.00%+5.39%+62.89%+53.44% 611B
-0.23%+6.88%+32.14%+86.34% 444B
+0.88%-0.96%+26.12%+20.22% 324B
+1.70%-0.26%+35.00%+35.20% 285B
+0.76%-0.17%+27.79%+42.06% 283B
-0.25%+2.19%-26.94%-40.41% 219B
-0.22%+2.82%+24.37%+62.75% 195B
-0.29%+0.65%+12.75%+63.45% 156B
Average +0.14%+2.83%+27.52%+53.02% 397.85B
Weighted average by Cap. -0.01%+4.16%+38.22%+77.24%
Logo Shire
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows: - sales of products (95.3%); - other (4.7%): primarily franchise royalties. Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
Employees
-